查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933099

全球免疫健康和疾病抵抗力快速消費品市場預測至2032年：按產品、營養類型、劑型、分銷管道、應用、最終用戶和地區分類

Immune Health & Disease Resistance FMCG Market Forecasts to 2032 - Global Analysis By Product, Nutrient Type, Form, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，全球免疫健康和疾病抵抗力快速消費品市場預計到 2025 年價值 492.9 億美元，到 2032 年達到 776.1 億美元，在預測期內以 6.7% 的複合年成長率成長。

免疫健康和疾病抵抗力快速消費品（FMCG）是指旨在支持、增強和維持人體天然免疫防禦能力，同時降低常見疾病易感性的消費品。此類別包括富含增強免疫力的維生素、礦物質、益生菌、植物萃取物和功能性成分的食品、飲料、膳食補充劑和日常用品。這些產品專為日常食用、預防保健和整體健康而設計，旨在滿足消費者尋求便捷解決方案以增強對感染疾病和生活方式相關健康挑戰的抵抗力的需求。

擴展腸道免疫軸

研究表明，益生菌、益生元和後生元在增強免疫反應方面發揮重要作用，這正在影響消費者的購買行為。食品飲料製造商正在加速開發有助於維持腸道菌叢平衡、提升免疫力的產品。人們日益認知到消化系統健康是疾病預防的基礎，這推動了機能性食品飲料產業的創新。腸道菌叢研究的進展使得更有針對性的成分開發成為可能。消費者正在積極尋求能夠提供全面免疫支持的產品，而非僅針對症狀的解決方案。這種模式轉移正在推動以免疫為重點的快速消費品類的長期成長。

監管複雜性與健康聲明

監管機構對成分檢驗、標籤標註和免疫相關益處的證明製定了嚴格的指導方針。製造商必須應對各地法規的差異，這增加了合規成本和產品上市時間。與疾病預防和增強免疫力相關的聲明通常需要大量的臨床證據。規模較小的快速消費品品牌在滿足文件和測試要求方面面臨許多挑戰。食品安全和膳食補充劑法規的頻繁更新進一步增加了產品核可的複雜性。這些監管障礙減緩了創新步伐，並限制了積極的行銷策略。

人工智慧驅動的個人化營養

人工智慧平台分析消費者數據、生活方式因素和健康指標，從而推薦個人化最佳化的免疫支援產品。企業正利用數位化工具，根據年齡、壓力水平和飲食習慣來定製配方。針對特定需求的個人化免疫解決方案正受到注重健康的消費者的青睞。穿戴式科技和健康應用程式的進步正在強化數據驅動的營養生態系統。快速消費品公司正與醫療科技公司合作，以提升其個人化能力。人工智慧與營養的融合正在改變產品差異化和消費者互動方式。

偽造和防篡改

假冒偽劣免疫保健產品的氾濫對市場信譽構成嚴重威脅。未經授權的產品往往含有劣質或有害成分，損害消費者信任。某些地區供應鏈監管薄弱，使得仿冒品得以在零售和線上市場流通。監管機構正在加強監管，但各市場的執法力度仍參差不齊。仿冒品的氾濫對品牌造成了聲譽損害和經濟損失。儘管先進的追溯技術正在廣泛應用，但實施成本仍然很高。

新冠疫情的感染疾病：

新冠疫情顯著改變了快速消費品（FMCG）市場，尤其是免疫健康和疾病抵抗力相關的產品。消費者關注點急劇轉向預防保健、增強免疫力的食品和機能飲料。富含維生素、礦物質、植物萃取物和益生菌的產品需求激增。供應鏈中斷最初影響了原料採購和生產的連續性。然而，在疫情封鎖期間，數位商務和直接面對消費者（D2C）管道迅速擴張。各大品牌加快了創新步伐，以滿足消費者日益成長的免疫意識。疫情過後，免疫健康已從被動應對轉變為日常健康管理的重要環節。

預計在預測期內，機能飲料細分市場將佔據最大的市場佔有率。

預計在預測期內，機能飲料將佔據最大的市場佔有率。這些產品透過強化飲品，提供便利且快速吸收的免疫支持。維生素強化水、康普茶和免疫支持飲品的消費量不斷成長，推動了該細分市場的成長。飲料產品對年輕都市區消費者有著強大的吸引力。製造商正不斷創新，採用天然成分、低糖和潔淨標示配方。快節奏生活方式的興起也進一步推動了飲料的流行。

認知壓力因應支持細分市場在預測期內將呈現最高的複合年成長率

預計在預測期內，認知壓力因應支持領域將達到最高成長率。需求成長主要源自於人們對壓力、免疫力和心理健康之間關聯的認知不斷提高。消費者正在尋找能夠同時增強免疫力、改善情緒和提升認知能力的保健產品。適應原、益智藥和功能性植物萃取物等成分正日益受到歡迎。日益加劇的職場壓力和數位疲勞正在影響消費者的購買決策。各大品牌正將壓力免疫解決方案定位為日常健康生活方式的一部分。

佔比最大的地區：

預計北美將在預測期內佔據最大的市場佔有率。消費者對預防性醫療保健的高度重視推動了產品的強勁成長。該地區受益於先進的零售基礎設施和機能性食品的高滲透率。主要快速消費品公司持續投資於以增強免疫力為重點的產品研發。膳食補充劑監管政策的明朗化有助於市場穩定。強大的購買力也促進了高級產品的消費。

年複合成長率最高的地區：

預計亞太地區在預測期內將實現最高的複合年成長率。快速的都市化和不斷成長的可支配收入正在推動免疫健康產品的消費。傳統醫療體系與現代快速消費品模式的融合正在加速。疫情後人們健康意識的提高正在加速需求成長。不斷壯大的中產階級正在接受機能性食品和飲料。電子商務的成長提高了全部區域產品的可及性。

免費客製化服務：

購買此報告的客戶可以選擇以下免費自訂選項之一：

  • 公司概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 主要參與者（最多3家公司）的SWOT分析
  • 區域細分
    • 根據客戶要求，對主要國家進行市場估算和預測，並計算複合年成長率（註：可行性需確認）。
  • 競爭標竿分析
    • 基於產品系列、地域覆蓋範圍和策略聯盟對主要參與者進行基準分析

目錄

第1章執行摘要

第2章 前言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球免疫健康與疾病抵抗力快速消費品市場（依產品區分）

  • 機能飲料
  • 機能性食品
  • 強化乳製品/替代品
  • 免疫功能烘焙和糖果甜點
  • 含有營養功能成分的快速消費品
  • 運動營養
  • 免疫增強針劑/濃縮液
  • 其他

6. 全球免疫健康和疾病抵抗力快速消費品市場（按營養類型分類）

  • 維他命
  • 礦物
  • 益生菌和益生元
  • 草藥和植物萃取物
  • Omega-3脂肪酸
  • 其他

7. 全球免疫健康和疾病抵抗力快速消費品市場（按類型分類）

  • 液體/飲料
  • 粉末混合物
  • 片劑和膠囊
  • 軟糖/咀嚼片
  • 酒吧和小吃店

8. 全球免疫健康和疾病抵抗力快速消費品市場（按分銷管道分類）

  • 超級市場和大賣場
  • 藥房和藥品商店
  • 便利商店和專賣店
  • 線上/電商零售
  • 直銷/多層次傳銷管道
  • MT vs. TT

9. 全球免疫健康和疾病抵抗力快速消費品市場（按應用領域分類）

  • 一般免疫支持
  • 季節性健康支持
  • 腸道和消化系統中的免疫相互作用
  • 從疾病中康復
  • 能量和免疫支持
  • 認知壓力韌性支持
  • 其他

第10章 全球免疫健康和疾病抵抗力快速消費品市場（按最終用戶分類）

  • 成人
  • 兒童和青少年
  • 老年人
  • 基於性別的
  • 其他

第11章 全球免疫健康與疾病抵抗力快速消費品市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章：企業概況

  • Nestle SA
  • Danone SA
  • Amway Corporation
  • Herbalife Nutrition Ltd.
  • Abbott Laboratories
  • Bayer AG
  • Pfizer Inc.
  • GlaxoSmithKline plc（GSK）
  • Unilever plc
  • PepsiCo, Inc.
  • Blackmores Limited
  • Nature's Bounty Co.
  • NOW Foods
  • Yakult Honsha Co., Ltd.
  • Hain Celestial Group, Inc.
Product Code: SMRC33667

According to Stratistics MRC, the Global Immune Health & Disease Resistance FMCG Market is accounted for $49.29 billion in 2025 and is expected to reach $77.61 billion by 2032 growing at a CAGR of 6.7% during the forecast period. Immune Health & Disease Resistance FMCG refers to fast-moving consumer goods formulated to support, strengthen, and maintain the body's natural immune defenses while reducing susceptibility to common illnesses. This category includes foods, beverages, supplements, and daily-use products enriched with vitamins, minerals, probiotics, botanicals, and functional ingredients that enhance immunity. These products are designed for regular consumption, preventive health management, and overall wellness, catering to consumers seeking convenient, accessible solutions to improve resilience against infections and lifestyle-related health challenges.

Market Dynamics:

Driver:

Expansion of the gut-immune axis

Research highlighting the role of probiotics, prebiotics, and postbiotics in strengthening immune responses is influencing consumer purchasing behavior. Food and beverage manufacturers are increasingly formulating products that support microbiome balance to enhance immunity. Rising awareness of digestive health as a foundation for disease prevention is accelerating innovation in functional foods and beverages. Advancements in microbiome research are enabling more targeted ingredient development. Consumers are actively seeking products that offer holistic immune support rather than symptom-based solutions. This paradigm shift is reinforcing long-term growth across immune-focused FMCG categories.

Restraint:

Regulatory complexity & health claims

Authorities enforce strict guidelines on ingredient validation, labeling, and substantiation of immunity-related benefits. Manufacturers must navigate varying regulations across regions, increasing compliance costs and time-to-market. Claims linked to disease prevention or immune enhancement often requires extensive clinical evidence. Smaller FMCG brands face difficulties meeting documentation and testing requirements. Frequent updates to food safety and nutraceutical regulations further complicate product approvals. These regulatory hurdles slow innovation and limit aggressive marketing strategies.

Opportunity:

AI-driven personalized nutrition

AI-powered platforms analyze consumer data, lifestyle factors, and health metrics to recommend tailored immune-support products. Companies are leveraging digital tools to customize formulations based on age, stress levels, and dietary habits. Personalized immune solutions are gaining traction among health-conscious consumers seeking targeted benefits. Advances in wearable technology and health apps are strengthening data-driven nutrition ecosystems. FMCG players are partnering with health-tech firms to enhance personalization capabilities. This convergence of AI and nutrition is reshaping product differentiation and consumer engagement.

Threat:

The counterfeit & adulteration crisis

The increasing prevalence of counterfeit and adulterated immune health products poses a serious threat to market credibility. Unauthorized products often contain substandard or harmful ingredients, eroding consumer trust. Weak supply chain oversight in certain regions enables counterfeit goods to penetrate retail and online channels. Regulatory bodies are intensifying surveillance, but enforcement remains inconsistent across markets. Brands face reputational damage and financial losses due to counterfeit proliferation. Advanced traceability technologies are being adopted, though implementation costs remain high.

Covid-19 Impact:

The COVID-19 pandemic significantly reshaped the immune health and disease resistance FMCG market. Consumer focus shifted sharply toward preventive health, immunity-boosting foods, and functional beverages. Demand surged for products containing vitamins, minerals, botanicals, and probiotics. Supply chain disruptions initially affected ingredient sourcing and manufacturing continuity. However, digital commerce and direct-to-consumer channels expanded rapidly during lockdowns. Brands accelerated innovation cycles to meet heightened immunity awareness. Post-pandemic, immune health has transitioned from a reactive to a daily wellness priority.

The functional beverages segment is expected to be the largest during the forecast period

The functional beverages segment is expected to account for the largest market share during the forecast period. These products offer convenient and fast-absorbing immune support through fortified drinks. Growing consumption of vitamin-enriched waters, kombucha, and immunity shots is fueling segment expansion. Beverage formats appeal strongly to younger demographics and urban consumers. Manufacturers are innovating with natural ingredients, reduced sugar, and clean-label formulations. Increased on-the-go lifestyles further support beverage adoption.

The cognitive stress resilience support segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cognitive stress resilience support segment is predicted to witness the highest growth rate. Rising awareness of the link between stress, immunity, and mental health is driving demand. Consumers are seeking products that combine immune defense with mood and cognitive support. Ingredients such as adaptogens, nootropics, and functional botanicals are gaining popularity. Increasing workplace stress and digital fatigue are influencing purchasing decisions. Brands are positioning stress-immunity solutions as part of daily wellness routines.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. High consumer awareness regarding preventive healthcare supports strong product adoption. The region benefits from advanced retail infrastructure and high penetration of functional foods. Major FMCG companies continuously invest in immune-focused product innovation. Regulatory clarity around dietary supplements enhances market stability. Strong purchasing power enables premium product consumption.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid urbanization and rising disposable incomes are driving immune health product consumption. Traditional medicine systems combined with modern FMCG formats are gaining traction. Increasing health awareness following pandemic experiences is accelerating demand. Expanding middle-class populations are adopting functional foods and beverages. E-commerce growth is improving product accessibility across the region.

Key players in the market

Some of the key players in Immune Health & Disease Resistance FMCG Market include Nestle S.A., Danone S.A., Amway Corporation, Herbalife Nutrition Ltd., Abbott Laboratories, Bayer AG, Pfizer Inc., GlaxoSmithKline plc (GSK), Unilever plc, PepsiCo, Inc., Blackmores Limited, Nature's Bounty Co., NOW Foods, Yakult Honsha Co., Ltd., and Hain Celestial Group, Inc.

Key Developments:

In December 2025, Nestle's iconic Maggi brand has teamed up with Ninja, to deliver innovative air fryer solutions to consumers in the Middle East and North Africa (MENA). Building on the rising popularity of these novel kitchen appliances in the region, this collaboration aims to inspire wholesome, more convenient, delicious home cooking.

In September 2025, Davenport University and Amway sign partnership to spur talent development. Leaders from Davenport University and Amway formalized their commitment to higher education and talent development with a signing ceremony held at the Amway headquarters in Ada, located a few miles east of the city of Grand Rapids. The agreement, signed September 29, 2025, provides scholarship opportunities for employees of Amway and their family members.

Products Covered:

  • Functional Beverages
  • Functional Foods
  • Fortified Dairy & Alternatives
  • Bakery & Confectionery with Immunity Claims
  • Nutraceutical-Infused FMCG Products
  • Sports & Performance Nutrition Products
  • Immune Shots & Concentrates
  • Other Products

Nutrient Types Covered:

  • Vitamins
  • Minerals
  • Probiotics & Prebiotics
  • Herbal & Botanical Extracts
  • Omega-3 & Fatty Acids
  • Other Nutrient TypeS

Forms Covered:

  • Liquids & Drinks
  • Powder Mixes
  • Tablets & Capsules
  • Gummies & Chewables
  • Bars & Snack Formats

Distribution Channels Covered:

  • Supermarkets & Hypermarkets
  • Pharmacy & Drug Retail
  • Convenience & Specialty Stores
  • Online / E-Commerce Retail
  • Direct Selling & MLM Channels
  • Modern Trade vs Traditional Trade

Applications Covered:

  • General Immune Support
  • Seasonal Wellness Support
  • Gut & Digestive Immune Interaction
  • Post-Illness Recovery
  • Energy + Immune Support
  • Cognitive Stress Resilience Support
  • Other Applications

End Users Covered:

  • Adults
  • Children & Teens
  • Elderly
  • Gender-Based
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Immune Health & Disease Resistance FMCG Market, By Product

  • 5.1 Introduction
  • 5.2 Functional Beverages
  • 5.3 Functional Foods
  • 5.4 Fortified Dairy & Alternatives
  • 5.5 Bakery & Confectionery with Immunity Claims
  • 5.6 Nutraceutical-Infused FMCG Products
  • 5.7 Sports & Performance Nutrition Products
  • 5.8 Immune Shots & Concentrates
  • 5.9 Other Products

6 Global Immune Health & Disease Resistance FMCG Market, By Nutrient Type

  • 6.1 Introduction
  • 6.2 Vitamins
  • 6.3 Minerals
  • 6.4 Probiotics & Prebiotics
  • 6.5 Herbal & Botanical Extracts
  • 6.6 Omega-3 & Fatty Acids
  • 6.7 Other Nutrient TypeS

7 Global Immune Health & Disease Resistance FMCG Market, By Form

  • 7.1 Introduction
  • 7.2 Liquids & Drinks
  • 7.3 Powder Mixes
  • 7.4 Tablets & Capsules
  • 7.5 Gummies & Chewables
  • 7.6 Bars & Snack Formats

8 Global Immune Health & Disease Resistance FMCG Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Supermarkets & Hypermarkets
  • 8.3 Pharmacy & Drug Retail
  • 8.4 Convenience & Specialty Stores
  • 8.5 Online / E-Commerce Retail
  • 8.6 Direct Selling & MLM Channels
  • 8.7 Modern Trade vs Traditional Trade

9 Global Immune Health & Disease Resistance FMCG Market, By Application

  • 9.1 Introduction
  • 9.2 General Immune Support
  • 9.3 Seasonal Wellness Support
  • 9.4 Gut & Digestive Immune Interaction
  • 9.5 Post-Illness Recovery
  • 9.6 Energy + Immune Support
  • 9.7 Cognitive Stress Resilience Support
  • 9.8 Other Applications

10 Global Immune Health & Disease Resistance FMCG Market, By End User

  • 10.1 Introduction
  • 10.2 Adults
  • 10.3 Children & Teens
  • 10.4 Elderly
  • 10.5 Gender-Based
  • 10.6 Other End Users

11 Global Immune Health & Disease Resistance FMCG Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Nestle S.A.
  • 13.2 Danone S.A.
  • 13.3 Amway Corporation
  • 13.4 Herbalife Nutrition Ltd.
  • 13.5 Abbott Laboratories
  • 13.6 Bayer AG
  • 13.7 Pfizer Inc.
  • 13.8 GlaxoSmithKline plc (GSK)
  • 13.9 Unilever plc
  • 13.10 PepsiCo, Inc.
  • 13.11 Blackmores Limited
  • 13.12 Nature's Bounty Co.
  • 13.13 NOW Foods
  • 13.14 Yakult Honsha Co., Ltd.
  • 13.15 Hain Celestial Group, Inc.

List of Tables

  • Table 1 Global Immune Health & Disease Resistance FMCG Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Immune Health & Disease Resistance FMCG Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Immune Health & Disease Resistance FMCG Market Outlook, By Functional Beverages (2024-2032) ($MN)
  • Table 4 Global Immune Health & Disease Resistance FMCG Market Outlook, By Functional Foods (2024-2032) ($MN)
  • Table 5 Global Immune Health & Disease Resistance FMCG Market Outlook, By Fortified Dairy & Alternatives (2024-2032) ($MN)
  • Table 6 Global Immune Health & Disease Resistance FMCG Market Outlook, By Bakery & Confectionery with Immunity Claims (2024-2032) ($MN)
  • Table 7 Global Immune Health & Disease Resistance FMCG Market Outlook, By Nutraceutical-Infused FMCG Products (2024-2032) ($MN)
  • Table 8 Global Immune Health & Disease Resistance FMCG Market Outlook, By Sports & Performance Nutrition Products (2024-2032) ($MN)
  • Table 9 Global Immune Health & Disease Resistance FMCG Market Outlook, By Immune Shots & Concentrates (2024-2032) ($MN)
  • Table 10 Global Immune Health & Disease Resistance FMCG Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 11 Global Immune Health & Disease Resistance FMCG Market Outlook, By Nutrient Type (2024-2032) ($MN)
  • Table 12 Global Immune Health & Disease Resistance FMCG Market Outlook, By Vitamins (2024-2032) ($MN)
  • Table 13 Global Immune Health & Disease Resistance FMCG Market Outlook, By Minerals (2024-2032) ($MN)
  • Table 14 Global Immune Health & Disease Resistance FMCG Market Outlook, By Probiotics & Prebiotics (2024-2032) ($MN)
  • Table 15 Global Immune Health & Disease Resistance FMCG Market Outlook, By Herbal & Botanical Extracts (2024-2032) ($MN)
  • Table 16 Global Immune Health & Disease Resistance FMCG Market Outlook, By Omega-3 & Fatty Acids (2024-2032) ($MN)
  • Table 17 Global Immune Health & Disease Resistance FMCG Market Outlook, By Other Nutrient TypeS (2024-2032) ($MN)
  • Table 18 Global Immune Health & Disease Resistance FMCG Market Outlook, By Form (2024-2032) ($MN)
  • Table 19 Global Immune Health & Disease Resistance FMCG Market Outlook, By Liquids & Drinks (2024-2032) ($MN)
  • Table 20 Global Immune Health & Disease Resistance FMCG Market Outlook, By Powder Mixes (2024-2032) ($MN)
  • Table 21 Global Immune Health & Disease Resistance FMCG Market Outlook, By Tablets & Capsules (2024-2032) ($MN)
  • Table 22 Global Immune Health & Disease Resistance FMCG Market Outlook, By Gummies & Chewables (2024-2032) ($MN)
  • Table 23 Global Immune Health & Disease Resistance FMCG Market Outlook, By Bars & Snack Formats (2024-2032) ($MN)
  • Table 24 Global Immune Health & Disease Resistance FMCG Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 25 Global Immune Health & Disease Resistance FMCG Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 26 Global Immune Health & Disease Resistance FMCG Market Outlook, By Pharmacy & Drug Retail (2024-2032) ($MN)
  • Table 27 Global Immune Health & Disease Resistance FMCG Market Outlook, By Convenience & Specialty Stores (2024-2032) ($MN)
  • Table 28 Global Immune Health & Disease Resistance FMCG Market Outlook, By Online / E-Commerce Retail (2024-2032) ($MN)
  • Table 29 Global Immune Health & Disease Resistance FMCG Market Outlook, By Direct Selling & MLM Channels (2024-2032) ($MN)
  • Table 30 Global Immune Health & Disease Resistance FMCG Market Outlook, By Modern Trade vs Traditional Trade (2024-2032) ($MN)
  • Table 31 Global Immune Health & Disease Resistance FMCG Market Outlook, By Application (2024-2032) ($MN)
  • Table 32 Global Immune Health & Disease Resistance FMCG Market Outlook, By General Immune Support (2024-2032) ($MN)
  • Table 33 Global Immune Health & Disease Resistance FMCG Market Outlook, By Seasonal Wellness Support (2024-2032) ($MN)
  • Table 34 Global Immune Health & Disease Resistance FMCG Market Outlook, By Gut & Digestive Immune Interaction (2024-2032) ($MN)
  • Table 35 Global Immune Health & Disease Resistance FMCG Market Outlook, By Post-Illness Recovery (2024-2032) ($MN)
  • Table 36 Global Immune Health & Disease Resistance FMCG Market Outlook, By Energy + Immune Support (2024-2032) ($MN)
  • Table 37 Global Immune Health & Disease Resistance FMCG Market Outlook, By Cognitive Stress Resilience Support (2024-2032) ($MN)
  • Table 38 Global Immune Health & Disease Resistance FMCG Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 39 Global Immune Health & Disease Resistance FMCG Market Outlook, By End User (2024-2032) ($MN)
  • Table 40 Global Immune Health & Disease Resistance FMCG Market Outlook, By Adults (2024-2032) ($MN)
  • Table 41 Global Immune Health & Disease Resistance FMCG Market Outlook, By Children & Teens (2024-2032) ($MN)
  • Table 42 Global Immune Health & Disease Resistance FMCG Market Outlook, By Elderly (2024-2032) ($MN)
  • Table 43 Global Immune Health & Disease Resistance FMCG Market Outlook, By Gender-Based (2024-2032) ($MN)
  • Table 44 Global Immune Health & Disease Resistance FMCG Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.